2012 quality and patient safety performance results annual report the quality committee of the board...

37
2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages 1-31 of this material has been prepared under the direction of the director of Quality/Patient Safety Officer as part of the delegated responsibilities of the role to ensure the state and federal protections: Pursuant to GPR Statutes Georgia Code Sections 31.7.130-133.3, and Federal Immunity under the HCQI Act 1986. 1

Upload: griffin-porter

Post on 24-Dec-2015

219 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

2012 Quality and Patient SafetyPerformance Results

Annual Report The Quality Committee of the Board

Confidential & Privileged Peer Review Materials; Pages 1-31 of this material has been prepared under the direction of the director of Quality/Patient Safety Officer as part of the delegated responsibilities of the role to ensure the state and federal protections:Pursuant to GPR Statutes Georgia Code Sections 31.7.130-133.3, and Federal Immunity under the HCQI Act 1986.

1

Page 2: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Table of Contents

Downstream Impact: Affordable Care Act #Understanding the Clinical Climate #Patients with Underlying Conditions #Advancement of Safe and Reliable Care #Focus on Harm Reduction: Healthcare Acquired Conditions #Executive Summary #Healthcare Acquired Condition Reports - 2012 #-#Organizational Responsiveness to Quality and Patient Safety Issues #-#

2

Page 3: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

One is Too Many

Harm from the Patient’s Point of View

3

Page 4: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Down Stream Impact: Affordable Care Act

CMS & Innovation Center (CMMI)

$1B to Partnership for Patient Safety (PfP) to Achieve 2 Goals 2013:

1. Reduce HAC’s by 40%

2. Reduce Re-admissions by 20%

State level - Healthcare Engagement Networks (HEN’s):

• 26 HEN’s Across Country

GA HEN / Georgia Hospital Association:

• Drive improvement of 10 HAC’s

Local Accountability for [Organization]:

• Reduce Harm for ___ HAC’s

• Demonstrate Best Practice

• Influence policy

• Report Data to CMS

Pa

y for P

erfo

rma

nce

4

Page 5: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

• Patient Volume [amount of change] from 2011 to 2012.

• Total Number of Patient Days [amount of change] from 2011 to 2012.

• Administered doses of medication [amount of change] (__ for Inpatient and __ for

Outpatient) from 2011 to 2012.

Understanding the Clinical Climate of 2012

5

Page 6: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Patients with Underlying Conditions

Most complex secondary med mgmt Least complex secondary med mgmtSingle Focused Injury

6

[Graph of Comorbiditites by Tier]

Tier 0 Tier 1 Tier 2Tier 3

Page 7: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Approach

Advancement of Safe and Reliable Care THROUGH:

Safe andReliable Care

Standardize:High Risk Practice

Mindful:Delivery of Care

Engage:Patients and Families

Adoption:Scientific Evidence

7

Page 8: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Focus on Reduction of Harm

CLABSI(Central Line Associated Blood Stream Infection)

Adverse Drug Events(INR/Glycemic)

CAUTI(Catheter Associated Urinary Tract Infection)

Pressure Ulcers

VAP(Ventilator Associated Pneumonia)

VTE(Deep Vein Thrombosis)

Falls with HarmPreventable Readmissions (within 30 days of discharge and readmit to a Georgia hospital)

8

Page 9: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Healthcare Acquired Conditions 2012 Rate

2012 # Patients

2013CMS Target*

Advancement of Safe & Reliable CarePg.#Evidence Engage Mindful Standardize

CLABSI*(Central Line Associated Blood Stream Infection)

• Blood stream infection related to a central venous catheter

• Per 1,000 device days0.48 10

CAUTI*(Catheter Associated Urinary Tract Infection)

• Urinary tract infection related to indwelling catheter

• Per 1,000 catheter days0.48 13

VAP(Ventilator Associated Pneumonia)

• Confirmed Pneumonia related to a mechanical ventilator

• Per 1,000 ventilator days0.66 16

Falls with Harm • Fall resulting in injury (category E-I)• Per 1,000 patient days 0.5 18

Inpatient Fall Rate• Assisted and Unassisted Falls –

Inpatient only• Per 1,000 patient days

2.15 21

Adverse Drug Events • Adverse Drug Events with harm (category E-I)

• Per 1,000 Doses

5% pts. INR>57% pts. BG<50 22

Pressure Ulcers*• New Stage III, Stage IV, and

Unstageable PU’s• Per 1,000 Discharges

3.21 25

VTE(Pulmonary Embolism/Deep Vein Thrombosis)

• Any Patient with pulmonary embolism or deep vein thrombosis

• Per 1,000 Discharges5.56

28

Preventable Readmissions

• Unplanned all cause readmission within 30 days Medicare

• # Readmissions / Discharges

20%Reduction

from Baseline

Organizational Responsiveness to Quality and Patient Safety Issues

• Reportable Sentinel Events

31• Serious Adverse Events thatTriggered Drill Down

* Worst, acceptable rates established by CMS: Effective 2013 **Mandated by CMS LTCH Quality Reporting Program: Effective October 2012

Page 10: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Central Line Associated Blood Stream Infections CLABSI

# Patient Harms

10

[note: Include 1 icon for each harm]

Page 11: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

The Person

• [Patient Profile]

The Story of CLABSI Harm• [Story of patient Harm]

Central Line Associated Blood Stream Infections CLABSI

Harm from the Patients Perspective

The Impact/Temporary• [Impact of patient Harm]

The Discharge• [Patient’s discharge status]

11

Page 12: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Central Line Associated Blood Stream Infections CLABSI

Definition: Rate based on the total number of inpatients with confirmed blood stream infection per 1,000 central line days, based on CDC definition

2012 Rate:

2013 CMS Target: 0.48 / 1,000 device days

2012 Performance: • [Summary]

Potential Cost of Harm: $45,000 / hospital stay2

12

[Control Chart of CLABSI Rate]

Page 13: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Catheter Associated Urinary Tract Infections CAUTI

# Patient Harms

13

[note: Include 1 icon for each harm]

Page 14: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Catheter Associated Urinary Tract Infections CAUTI

Harm from the Patients Perspective

14

The Person

• [Patient Profile]

The Story of CAUTI Harm• [Story of patient Harm]

The Impact/Temporary• [Impact of patient Harm]

The Discharge• [Patient’s discharge status]

Page 15: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Catheter Associated Urinary Tract Infections CAUTI

Definition: Rate based on the number of patients with indwelling catheters who are symptomatic with confirmed infection per 1000 catheter days, based on CDC definition.

2012 Rate:

2013 CMS Target: 0.48 / 1,000 catheter days

2012 Performance:• [Summary]

Potential Cost of Harm: $44,043 / hospital stay8

15

[Control Chart of CAUTI Rate]

Page 16: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Ventilator Associated Pneumonia VAP

ZERO Patient Harm

____ Days : free from Harm

____ Years: based on the CDC definition

+

____ Patients: were kept free from Ventilator Harm

16

Page 17: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Ventilator Associated Pneumonia VAP

Definition: Rate based on total number of inpatients with confirmed infection per 1,000 ventilator days. National Healthcare Safety Network's definition of VAP: patient on ventilator, physician diagnosis of pneumonia post admission based on diagnostic, imaging, and/or laboratory results.

2012 Rate:

2013 CMS Target: 0.66 / 1,000 vent days

2012 Performance:• [Summary]

Potential Cost of Harm: $40,000 / hospital stay1

17

[Control Chart of VAP Rate and Device Utilization]

Page 18: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Falls with Harm

# Patient Harm

18

[note: Include 1 icon for each harm]

Page 19: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Falls with Harm

Harm from the Patients Perspective

19

The Person

• [Patient Profile]

The Story of Fall with Harm• [Story of patient Harm]

The Impact/Temporary• [Impact of patient Harm]

The Discharge• [Patient’s discharge status]

Page 20: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Falls with Harm

Definition: Figures are based on number of individual falls with harm reported through incident reports. The hybrid scale developed by Georgia Hospital Association (GHA) defines categories E - I as "with harm." The range is between temporary harm, prolonged hospitalization, permanent harm, near death and death.

2012 Rate:

2013 CMS Target: 0.5 injury falls / 1,000 pt. days

2012 Performance:• [Summary]

Potential Cost of Harm: Variable

20

[Control Chart of Falls with Harm Rate]

Page 21: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Inpatient Fall Rate

Definition: Individual inpatient falls are reported through incident reports capturing assisted and unassisted falls. Rate is number of falls per 1,000 pt days

2012 Rate:

2013 CMS Target: 2.15 / 1,000 patient days

2012 Performance:• [Summary]

Potential Cost of Harm: Variable

21

[Control Chart of Assisted Falls Rate]

[Control Chart of Unassisted Falls Rate]

Page 22: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Adverse Drug Events ADE

22

# Patient Harms

[note: Include 1 icon for each harm]

Page 23: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Adverse Drug Events ADE

Harm from the Patients Perspective

23

The Person

• [Patient Profile]

The Story of ADE Harm• [Story of patient Harm]

The Impact/Temporary• [Impact of patient Harm]

The Discharge• [Patient’s discharge status]

Page 24: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Adverse Drug Events ADE

Definition: Harm is defined on a scale developed by Georgia Hospital Association, categories E - I (temporary Harm to Death). Figures based on number of individual medication incidents with harm as reported through incident reports.

2012 Rate:

2013 CMS Target: 5% INR>5 & 7% BG<50

2012 Performance:• [Summary]

Potential Cost of Harm: Variable

24

[Control Chart of ADE Rate]

Page 25: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Pressure Ulcers

25

# Patient Harms

[note: Include 1 icon for each harm]

Page 26: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Pressure Ulcers

Harm from Patients Perspective

26

The Person

• [Patient Profile]

The Story of PU Harm• [Story of patient Harm]

The Impact/Temporary• [Impact of patient Harm]

The Discharge• [Patient’s discharge status]

Page 27: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Pressure Ulcers

Definition: Hospital Acquired Pressure Ulcers with Harm are Stage III and Stage IV pressure ulcers that developed while in the hospital.

2012 Rate:

2013 CMS Target: 3.21 / 1,000 discharges

2012 Performance:• [Summary]

Potential Cost of Harm: $1,600 / day4

27

[Control Chart of HA PU Rate]

Page 28: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Venous Thromboembolism VTE

28

# Patient Harms

[note: Include 1 icon for each harm]

Page 29: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Venous Thromboembolism VTEHarm from Patients Perspective

29

The Person

• [Patient Profile]

The Story of VTE Harm• [Story of patient Harm]

The Impact/Temporary• [Impact of patient Harm]

The Discharge• [Patient’s discharge status]

Page 30: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Definition: Any Patient with pulmonary embolism or deep vein thrombosis per 1,000 discharges

Venous Thromboembolism VTE

2012 Rate:

2013 CMS Target: 5.6 cases/1,000 discharges

2012 Performance:• [Summary]

Potential Cost of Harm: $19,000 (DVT)

$37,000 (PE)

30

[Control Chart of VTE Rate]

Page 31: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Preventable Readmissions

31

# Patient Harms

[note: Include 1 icon for each harm]

Page 32: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Preventable ReadmissionsHarm from Patients Perspective

32

The Person

• [Patient Profile]

The Story of Readmission Harm• [Story of patient Harm]

The Impact/Temporary• [Impact of patient Harm]

The Discharge• [Patient’s discharge status]

Page 33: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Definition: Definition: Unplanned all cause readmissions within 30 days - Medicare patients only

Preventable Readmissions

2012 Rate:

2013 CMS Target: Reduce hospital baseline by 20%

2012 Performance:• [Summary]

Potential Cost of Harm: TBD

33

[Control Chart of Readmission Rate]

Page 34: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Organizational Responsiveness to Quality and Patient Safety Issues

34

Page 35: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

Significance: A significant adverse event, also known as a sentinel event, is an unexpected occurrence involving death or serious physical or psychological injury or the risk thereof and signals the need for immediate drill down and organizational response.

The terms "sentinel" and "error" are not synonymous. Not all serious adverse (sentinel) events occur because of an error, and not all errors result in a serious adverse (sentinel) event.

Analysis:

Organizational Responsiveness to Quality and Patient Safety Issues

+

+

   Q1 Q2 Q3 Q4 2012 Total All Types  Medication Error

Procedural Error

Infection  

Allergy 

Delay in Care

35

Page 36: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

36

Page 37: 2012 Quality and Patient Safety Performance Results Annual Report The Quality Committee of the Board Confidential & Privileged Peer Review Materials; Pages

37